Namal Nawana is the new president of DePuy Spine, succeeding Gary Fischetti, who was named chairman of the DePuy group in January by its corporate parent, Johnson & Johnson (NYSE:JNJ).
Nawana, a 13-year vet at the New Brunswick, N.J.-based medical products conglomerate, pulled stints in several areas, including engineering, marketing, sales and general management in Europe, Canada, Australia and the Asia Pacific, according to a press release.
J&J tapped Fischetti to lead its DePuy orthopedics subsidiaries (DePuy Orthopaedics, DePuy Spine, DePuy Mitek and Codman & Shurtleff) last month, after 27 years with the company. Earlier this month, the company ousted DePuy Orthopaedics president David Floyd in the midst of a damaging recall of one of its hip replacement line that has already cost it nearly $1 billion in legal expenses.
Here’s a roundup of the latest personnel changes from medical device, diagnostics and life science companies around the nation:
- Tedeschi out, Hostelley in as CEO at Cardiovascular Medical Device Corp.
Carl Tedeschi resigned as CEO, CFO and director of Cardiovascular Medical Device Corp. march 10, replaced by David Hostelley, 71, the former CFO and board member of Entertainment Arts Research Inc.
- Streamline Health names Leach VP and CMO
Streamline Health Solutions Inc. (NSDQ:STRM) named Rick Leach senior vice president and chief marketing officer effective March 14.
- T2 Biosystems taps Poss to lead biz dev efforts
T2 Biosystems Inc. named Kirt Poss senior vice president of corporate development, charging him with leading T2’s market expansion strategy and related corporate partnerships.
Read more (PDF)
- MedPro Safety taps Schupp as COO
MedPro Safety Products hired Gregory Schupp to be its COO as of March 23. Schupp is a 20-year manufacturing veteran, most recently serving as director of operations and general manager of Sorin Group’s U.S. operations.
- Synexus names new Ukraine territory leader
Dmytro Razborov was appointed regional director for operations and business development of Synexus Ukraine.
- Crux Biomedical names Lindholm to board
Crux Biomedical appointed Randy Lindholm, former chairman and CEO of Vidamed until its 2002 buyout by Medtronic, to its board of directors.
- Neogen director Book steps down
Robert Book resigned from Neogen’s board of directors March 11 after 20 years, for “personal reasons.”
- Medisse names Pharmacell’s Vos to supervisory board
Medisse appointed Pharmacell CEO Alexander Vos to its supervisory board.